chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a female who on an unspecified date was vaccinated 0.5mL, IM with GARDASIL (dose and lot# not reported). Subsequently the patient experienced pain in the arm (left or right not specified) after her vaccination (unspecified if immediately or several days later). Subsequently, the patient "improved" and was able to use her arm by the time she left the office (unspecified if day of vaccination or several days later). The patient sought unspecified medical attention. Additional information has been requested.
8DEC98 itchy red rash all over-onset in AM;took DPH all day & rash resolved that noc;took DPH;9DEC98 PM p/bath;saw MD this AM was told was allerg rxn to Td;
pt 4 days p/vax devel a 2cm by 2cm lobular indurated mass in rt deltoid w/warmth & external erythema;
1/15 vaccination 1/18 I woke up because I was itching my skin; shedding / everywhere. I went to my PCM. Had a steroid shot. Helped for 1 day. Called back to PCM; prescribed a  course of steroids. Symptoms lasted for about a week.
Approximately 1 1/2 hr after immunization with Tdap vaccine; Employee developed dizziness, shakiness, syncope and was admitted to ER. There were some muscle facicidations seen in both arms. Complained of numbness around jaw. There was no redness or edema to immunization site, no rash, no swelling of mucus membranes, no wheezing, no shortness of breath, no edema.
found my mother lying on the floor Monday morning covered in feces...she had been extremely tired after shot.  Her Blood sugar was extremely elevated ...and she was dehydrated
Itchy throat, face, lips, & nose; chest tightness; symptoms ongoing at time of report; tx: Benadryl 50mg oral
got flu; fine now except for no energy; Initial information received on 15-Dec-2022 regarding an unsolicited valid Social Media non-serious case received via consumer/non-healthcare professional.  This case involves an unknown age and unknown gender patient who got flu and fine now except for no energy after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, form, batch lot number, expiry date: unknown) via unknown route in unknown administration site for Prophylactic vaccination.  On an unknown date the patient developed a non-serious got flu (influenza), fine now except for no energy (asthenia) (unknown latency) following the administration of influenza vaccine.  Action taken with influenza vaccine was unknown.  It was not reported if the patient received a corrective treatment for the events.  Outcome: Unknown.
Vertigo, palpitations, frequent PVCs. Referred to ER for cardiology evaluation. Large localized erythema following vaccine at site. Murmur II/II (new). Dental abscess. Reporter confirmed that pt was not admitted to hospital but was observed in ER 4-5 hrs. Pt found to be hypokalemic and this was thought to be the cause of her PVC's. She improved significantly after treatment and treatment and is doing well but with occassional PVC's. The murmur and dental abscess were noted in early May 4-5 wks s/p onset of AE.
Neck stiffness; Soreness at injection site; Tiredness; Stomach cramping; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 02Mar2021 at 15:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The medical history included myasthenia gravis, fibromyalgia, osteoarthritis (OA), rheumatoid arthritis (RA), heart arrhythmia, asthma and allergy to bee venom. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The concomitant medications included gabapentin (MANUFACTURER UNKNOWN), flecainide (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and clotrimazole (MYCO) for unknown indications from unknown dates and unknown if ongoing. The patient previously took hydrocodone(MANUFACTURER UNKNOWN) on an unknown date and experienced allergy. On 02Mar2021 at 19:45, the patient experienced neck stiffness, soreness at injection site, tiredness, stomach cramping and diarrhea. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events neck stiffness, soreness at injection site, tiredness, stomach cramping and diarrhea was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a registered nurse concerning a patient at an elementary school who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient developed a mild case of breakthrough varicella. There was no product complaint involved. Additional information has been requested.
Menstruation started 12 days early on an otherwise very regular cycle and has lasted 8 days so far, 3 days longer than usual.
injection site discomfort, fatigued, chills, headache, fever, face/fingers swollen,
Within 30 seconds of giving HPV child was sitting, fell back, neck turned to (R) and had rhythmic twitching of neck, head and (L) arm. After 15-20 seconds, child woke and asked what happened and c/o being very tired. Child monitored for 1 hour with continued tiredness but no more sz activity.
Pt states sore arm with slight limitation in range of motion. States she intends to see a doctor regarding the soreness. She had not taken any medication to help alleviate the discomfort. Recommended she could take ibuprofen in the interim.
patient was originally supposed to receive Menquadfi however due to availability the patient received Menveo/ patient's PCP wrote a prescription for a 2 dose primary vaccination 8 weeks apart and a booster dose with no reported AE.; Initial information received on 25-Jan-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 60 years old male patient who was originally supposed to receive MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI] however due to availability the patient received MENVEO/ patient's pcp wrote a prescription for a 2 dose primary vaccination 8 weeks apart and a booster dose with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE(Solution for injection) (lot number, expiry date, strength, route was unknown) in unknown administration site for prophylactic vaccination(Immunisation).   On an unknown date, the patient received an unknown dose of suspect MENVEO not produced by Sanofi Pasteur (lot number, expiry date, strength, route was unknown) in unknown administration site for prophylactic vaccination(Immunisation).   On an unknown date the patient was originally supposed to receive menquadfi however due to availability the patient received menveo/ patient's pcp wrote a prescription for a 2 dose primary vaccination 8 weeks apart and a booster dose with no reported ae. (off label use) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE and (unknown latency) following the administration of MENVEO.  Action taken: not applicable.  Outcome: Unknown
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in 2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroid" (unspecified if ongoing); "ADHD" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "known allergies Sulpha" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE, start date: 01Sep2002; STRATTERA, start date: 01Feb2021; ZOLOFT, start date: 04Oct2021. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: potential Paxlovid rebound. Return of Covid symptoms. Paxlovid rebound. Aches, fatigue, congestion. For event COVID 19, patient received Paxlovid treatment started on 19Dec2022 and stopped on 23Dec2022. Patient received other medication in 2weeks.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
1 ml dose of Moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of OVERDOSE (1 ml dose of Moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On 26-May-2021, the patient experienced OVERDOSE (1 ml dose of Moderna vaccine). On 26-May-2021, OVERDOSE (1 ml dose of Moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.
Dysfunctional uterine bleeding, without prior history of said WT = 100 lb.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Systemic: Visual Changes/Disturbances-Mild, Additional Details: Around 5 minutes after vaccine pt reported dizziness, nausea and double vision. Within 10 mins, pt said double vision went away but she was still dizzy. EMS was called and pt was taken for follow up at hospital.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients. Medical history and drug reactions/allergies were not reported. On an unknown date, the unspecified number of patients were vaccinated with PNEUMOVAX23 (lot, dose, route and indications not reported). Concomitant medication was not reported. On an unknown date, the unspecified number of patients experienced rash/swelling around injections site post PNEUMOVAX23 administration. The outcome of the event was not reported. This is one of two reports from the same source. Additional information has been requested.
Body aches, fatigue, malaise,  headache,  nausea, and vomiting the first day after the shot. symptoms continued after two weeks, was seen in the clinic; labs were done and sent home. More symptoms of fatigue headache, pain, diaphoresis, fainting , chest tightness ended up in the ED
Circular and warm swelling at the injection site, like a bubble where the injection was given. Did not go away for 15 minutes, pt was otherwise well. No pain or other adverse effects.
Suspected vaccination failure; I Had And Still Do Have The Shingles / I Have Had Them Again, After Vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles, burning sensation, pain and mastectomy.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case reported by the patient herself/himself The patient received the dose of Shingles vaccine and patient experienced shingles  The reporter stated that patient had shingles and that was rare case. The patient stated that the first time patient got shingles  The patient got vaccine and it did help to ease the pain but burning was unbelievable and he/she was like on fire. The burning was on side and back. The reporter stated that these all after the Mastectomy,which was much less painful than the shingles. The reporter stated that he/she would ran for the vaccine as he had it again and after the vaccine it did help a lot. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Narrative: Found to be COVID-19 Positive on3/9/2021 after first COVID-19 Vaccine on 3/5/2021. Was admitted for COVID-pneumonia on 3/14. After supportive therapy, patient was discharged on 3/16/21. Received 2nd dose on 3/26/21.
I experienced heart palpitations and my doctor referred me to a Cardiologist who ran a series of tests to find out what was going on with my heart. He prescribed Flecainide to help clear up the extra heart beats that I was experiencing. I am still taking the medication to keep my heart from having extra beats.
Redness swelling itching and hot to the touch at injection site. It?s sore to touch or even lay on
09/19/22 presents to Birth Center Triage for "contractions" "39w5d". PMHx of "allergic rhinitis, anemia"
This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was reported. The patient did not get the 1st dose of SHINGRIX at the reporter's facility. The patient experienced flu like symptoms after 1 to 2 days of the vaccination. The patient was not able to get out of bed for one and half days due to the symptoms. The reporter did not have the vaccine information.
Patient reported not feeling well, including feeling nauseous on her way to the bathroom. Patient reported feeling like she would faint. She went to a chair to sit down and notified pharmacy staff. Patient reported feeling warm and having chills. Slight heaviness in the chest was reported. She also reported blurred vision and seeing white spots. Tingling in her fingers was also reported.
Patient received her 1st dose COVID vaccine, Moderna, at 11:02AM, she was waiting in the waiting area. She became dizzy and light headed. While the pharmacy team was reaching to her chair, the patient's husband laid her on the floor.  (Pharmacy Manager) got to the patient 's side. She was awake, aware of her surrounding. I (staff pharmacist, administered the vaccine)  checked Pt's blood pressure, reading was 173/99. I gave few minutes to breath, rechecked her blood pressure in 2 minutes, it dropped down to159/82. Then rechecked it third time was 131/76. Patient was feeling fine, we gave her water and sat her on the chair. I checked her blood pressure again, reading was 117/66. Patient reported that she did not have breakfast, she ate a piece of candy, in 5 minute she stated that she feels just fine. Her husband reported that this is the fifth time she has this (unrelated to prior vaccinations). She doesn't have a PCP and has never checked for her previous events. Patient said she does not have a statement to write, she decided to leave the pharmacy area after assuring she feels normal.
Pt recvd vax & approx 4 hrs following vax exp nausea, vomiting of green material, rash, blood-shot eyes & malaise;
This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Oct2021 10:00 (Lot number: FF2590) at the age of 38 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: VYVANSE. Vaccination history included: Bnt162b2 (Dose Number: 1; Batch/Lot No: ELO140; Location of injection: Arm Right, Vaccine Administration Time: 01:00 PM, My husband and I had Covid at the end of Sep of this year, 2021. I recovered. We recovered and our taste and smell was completely back to normal for many weeks.), administration date: 18Dec2020, when the patient was 37 years old, for Covid-19 immunization, reaction(s): "I had Covid"; Bnt162b2 (Dose Number: 2; Batch/Lot No: EK9231; Location of injection: Arm Right, Vaccine Administration Time: 01:00 PM, My husband and I had Covid at the end of Sep of this year, 2021. I recovered), administration date: 15Jan2021, when the patient was 37 years old, for Covid-19 immunization, reaction(s): "I had Covid". The following information was reported: IMMUNISATION (non-serious) with onset 20Oct2021 10:00, outcome "unknown", described as "Booster shot"; PAROSMIA (non-serious) with onset 21Oct2021 09:00, outcome "not recovered", described as "Soap smells like vomit"; TASTE DISORDER (non-serious) with onset 21Oct2021 09:00, outcome "not recovered", described as "many foods taste like pond water". Therapeutic measures were not taken as a result of parosmia, taste disorder.  Additional information: Patient reported that since the Booster shot, my taste and smell is screwed up. The booster shot 100% caused this and it has not changed. Today is 01Dec and taste and smell has not improved. Patient did not have any known allergies. Patient did not tested positive for Covid-19 post vaccination.  No follow-up attempts are possible. No further information is expected.
PATIENT WAS NOT 18, PATIENT TURNS 18 IN OCTOBER 2021
Chills on and off started the night after vaccination Muscle ache  all day headache relieved by tylenol. Overall malaise
Migraine, lasted about 18 hours sore injection site still sore, fatigue, nauseousness
flu-like symptoms; dizziness; nausea; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), DIZZINESS (dizziness) and NAUSEA (nausea) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 14-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), DIZZINESS (dizziness) and NAUSEA (nausea). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), DIZZINESS (dizziness) and NAUSEA (nausea) had resolved. Not Provided    Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Event onset date updated as 14-APR-2021 and event outcome updated. Patient denied consent to follow up.
Extreme fatigue day of and day after shot.  Then, fine for 2 weeks.  2 weeks after the shot, at night while in bed, my back muscles were deeply aching and painful.  This pain was from my buttocks up to my shoulders.  This deep & painful ache, was only at night, prevented me from sleeping.  I began taking ibuprofen but it had limited effect.  3 weeks after the shot, my lips, nose and then my entire face became numb and my skin was on fire.  The nerve endings throughout my body are on fire, extremely sensitive and my body is warm although my body temperature is normal.  4 weeks after the shot, the deep muscle pain in my back went away and was replaced by pain in my spine.  This is persisting and is also preventing me from sleeping.  I am only able to sleep for 1-3 hours a night until the pain starts.  During the day, I do not feel pain and can even take a nap without incident.  I went to Urgent Care and they did a complete exam, including bloodwork (normal), covid test (negative).  They prescribed Naproxin for pain/inflammation and Metaxalone a muscle relaxant.  The pain persisted but the muscle relaxant helped.  I was very concerned about my facial numbness and I also lost some of my ability to taste food.  I tried to see a Neurologist, but could not get an appt.  They suggested I go to the ER.  The ER ran a CAT scan (normal), EKG (normal), blood test (normal).  I then went to see a chiropractor (yesterday 9/15)  who took X-rays and began treatment.  Last night I slept 2 hours.  I am at the end of my rope.  Am about to see an orthopedic to see if there is anything I can get for the pain so that I can sleep at night.